Literature DB >> 14972273

Selective arterial embolization for control of lower gastrointestinal bleeding: recommendations for a clinical management pathway.

Joshua S Gady1, Harry Reynolds, Adam Blum.   

Abstract

PURPOSE: Angiography remains as the modality of choice in the diagnosis of lower gastrointestinal bleeding. Traditionally, angiography is used for localization of a bleeding source for surgical resection. Advances in transcatheter techniques have allowed for hemorrhage control through embolization of bleeding points, without the need for emergent laparotomy.
METHODS: A series of 10 consecutive patients who underwent angiographic embolization for lower gastrointestinal hemorrhage was retrospectively reviewed. Success and complication rates, as well as post-embolization follow-up methods, were recorded.
RESULTS: Over a 3-year period, 10 angiographic embolizations were performed for lower gastrointestinal hemorrhage. Average age of the patients was 75 years. Source of hemorrhage included diverticular disease in 4 patients, cancer in 2, polyps in 2, angiodysplasia in 1, and anastomotic bleeding in 1. Six patients required no further therapy. Four patients went on to have surgery: Three secondary to recurrent hemorrhage, 1 due to sepsis from ischemic bowel necrosis. There were no deaths. Four patients had an abdominal and pelvic computed tomography (CT) scan within 48 hours of embolization. Four patients had a colonoscopy within 48 hours of the procedure.
CONCLUSIONS: Angiography remains an important diagnostic tool in the management of lower gastrointestinal bleeding. In addition, it is a safe and effective treatment option, especially in patients with high surgical risk. Hemorrhage control obtained in the angiography suite may allow for patient stabilization and resuscitation with staging and bowel preparation for surgery. Patients need to be carefully monitored for evidence of bowel ischemia through the use of colonoscopy or computed tomography.

Entities:  

Mesh:

Year:  2003        PMID: 14972273     DOI: 10.1016/S0149-7944(02)00749-3

Source DB:  PubMed          Journal:  Curr Surg        ISSN: 0149-7944


  6 in total

1.  Role of urgent contrast-enhanced multidetector computed tomography for acute lower gastrointestinal bleeding in patients undergoing early colonoscopy.

Authors:  Naoyoshi Nagata; Ryota Niikura; Tomonori Aoki; Shiori Moriyasu; Toshiyuki Sakurai; Takuro Shimbo; Masafumi Shinozaki; Katsunori Sekine; Hidetaka Okubo; Kazuhiro Watanabe; Chizu Yokoi; Mikio Yanase; Junichi Akiyama; Naomi Uemura
Journal:  J Gastroenterol       Date:  2015-03-27       Impact factor: 7.527

2.  Management of angiogram-negative acute colonic hemorrhage: safety and efficacy of colonoscopy-guided superselective embolization.

Authors:  J Heianna; T Miyauchi; H Yamano; K Yoshikawa; M Hashimoto; S Murayama
Journal:  Tech Coloproctol       Date:  2014-02-06       Impact factor: 3.781

3.  Severe acute lower gastrointestinal bleeding: risk factors for morbidity and mortality.

Authors:  Antonio Ríos; Mariano J Montoya; José M Rodríguez; Andrés Serrano; Joaquín Molina; Pablo Ramírez; Pascual Parrilla
Journal:  Langenbecks Arch Surg       Date:  2006-11-28       Impact factor: 3.445

4.  Bleeding recurrence in patients with gastrointestinal vascular malformation after thalidomide.

Authors:  Haiying Chen; Sengwang Fu; Nan Feng; Huimin Chen; Yunjie Gao; Yunjia Zhao; Hanbing Xue; Yao Zhang; Xiaobo Li; Jun Dai; Jingyuan Fang; Zhizheng Ge
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

Review 5.  Management of bleeding in palliative care patients in the general internal medicine ward: a systematic review.

Authors:  R Sood; M Mancinetti; D Betticher; B Cantin; A Ebneter
Journal:  Ann Med Surg (Lond)       Date:  2019-12-18

6.  Successful laparoscopic surgery combined with selective arterial embolization for bleeding due to jejunal angiodysplasia: a case report.

Authors:  Hitoshi Hara; Soji Ozawa; Kazuhito Nabeshima; Jun Koizumi
Journal:  BMC Surg       Date:  2020-10-31       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.